J Infect . A retrospective multicenter analysis of candidaemia among COVID-19 patients during the first UK pandemic wave

[tetano]

J Infect


. 2021 Feb 18;S0163-4453(21)00090-6.
doi: 10.1016/j.jinf.2021.02.020. Online ahead of print.
A retrospective multicenter analysis of candidaemia among COVID-19 patients during the first UK pandemic wave


Sarah Denny ¹ , Alireza Abdolrasouli ² , Tamador Elamin ³ , Ximena Gonzalo ⁴ , Scott Pallett ⁵ , Esmita Charani ⁶ , Aatish Patel ⁷ , Hugo Donaldson ⁸ , Stephen Hughes ⁷ , Darius Armstrong-James ⁹ , Luke Sp Moore ¹⁰ , Nabeela Mughal ¹⁰



Affiliations

• PMID: 33610684
• DOI: 10.1016/j.jinf.2021.02.020

No abstract availableKeywords: Coronavirus; Microbiology: Candidaemia; SARS-CoV-2.


Conflict of interest statement

Declaration of competing interests SC has received a research grants from the Scientific Exploration Society. EC has been paid for consultancy fees by bioMerieux. SH reports personal fees from Pfizer and Shionogi. DAJ holds share options in Pulmocide Ltd and has received research grants from Pulmocide Ltd, Gilead Sciences, Astellas and Pfizer. He has received speaker and consultancy fees from Astra-Zeneca, Pfizer, Gilead, and Astellas. LSPM has consulted for DNAelectronics (2015-18), Dairy Crest (2017–2018), Umovis Lab (2020), bioMerieux (2013-2020), received speaker fees from Profile Pharma (2018) and Pfizer (2018-2020), received research grants from the National Institute for Health Research (2013-2020), CW+ Charity (2018-2020), and Leo Pharma (2016), and received educational support from Eumedica (2016–2018). NM has received speaker fees from Beyer (2016) and Pfizer (2019) and received educational support from Eumedica (2016) and Baxter (2017). All other authors have no conflicts of interest to declare.